Nalaganje...
Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
Epidermal growth factor receptor (EGFR) plays critical roles in cell proliferation, tumorigenesis, and anti-cancer drug resistance. Overexpression and somatic mutations of EGFR result in enhanced cancer cell survival. Therefore, EGFR can be a target for the development of anti-cancer therapy. Patien...
Shranjeno v:
| izdano v: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769649/ https://ncbi.nlm.nih.gov/pubmed/31527477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091374 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|